you can see clearly now
MacuCLEAR, Inc. is focused on the design and development of small molecule products for ophthalmic treatments for age-related diseases of the eye. We are developing innovative eye drops for the leading causes of blindness and vision impairment such as Dry Age Related Macular Degeneration (dAMD) and Diabetic Retinopathy. MacuCLEAR is driving innovation with the development of an eye drop treatment for the dry form of AMD, which affects around 15 million Americans and 30 million people globally. Learn More